Introduction: The treatment of elderly multiple myeloma (MM) patients with autologous stem cell transplantation (ASCT) is a controversial procedure. Most clinical trials evaluating the safety and efficacy of ASCT have primarily included patients younger than 65 years.
Design And Methods: This was a retrospective analysis of patients with MM who underwent ASCT between 2008 and 2018.
Int J Lab Hematol
December 2022